fbpx

Gary Scheiner

Home/Gary Scheiner

About Gary Scheiner

This author has not yet filled in any details.
So far Gary Scheiner has created 53 blog entries.

In-Depth Review of Tandem t:slim with Control IQ

Pros & Cons of the Tandem t:slim with Control IQ Tandem t:slim with Control IQ: "Smahtah" than the average pump By Gary Scheiner MS, CDCES I’m a big [...]

In-Depth Review of Senseonics Eversense CGM And It’s Pros/Cons

I first learned about the Eversense implanted continuous glucose sensor while attending the American Association of Diabetes Educators annual conference.

By |2019-10-24T21:15:33+00:00October 24th, 2019|Categories: Thinking Like A Pancreas Blog|Tags: , , |13 Comments

FDA Recommendations For Diabetes Management Are Largely Ineffective

Diabetes management, if limited to FDA recommendations is largely ineffective.

ADA Scientific Sessions 2018: Gary’s Top-5 Observations

As usual, this year’s American Diabetes Association Scientific Sessions didn’t place much emphasis on a healthy lifestyle.  There was food everywhere, and trust me, we’re not talking fruits & veggies.  But there was a great deal of research presented on diabetes medications and devices. 

LOOP vs. Medtronic 670G

One of the best examples I’ve come across in the “regulation vs. right to choose” debate related to diabetes technology is the We Are Not Waiting movement within the diabetes space.

Choosing a CGM: 3 Heads are Better Than One

There is no doubt that CGM can improve the quality of life and blood sugar control for just about everyone with diabetes. But which system is best for you?

IDS Clinicians Offer Different Perspectives on the Medtronic 670G

IDS Clinicians Offer Different Perspectives on the Medtronic 670G after 10 days of use. Read what they have to say...

It’s Libre, Man! In-Depth Review of the Newly Approved Freestyle Libre

Diabetes educator, Gary Scheiner gives his in-depth review of the newly approved Abbott Freestyle Libre CGM continuous glucose monitor.

670G and Me: Insights and Incites on Medtronic’s Latest System

The 670G represents an important step towards fully automating glucose control. However, it is important to put it in the proper context and set expectations at an appropriate level.

Diabetes BLAME Game: When your sugars are up, is it the medication or your diet?

what happens when we eat with reckless abandon and blood glucose levels start to head in the wrong direction?  Being the responsible individuals we are, we usually place the blame squarely where it belongs: on our medication.

By |2017-07-13T22:05:59+00:00July 13th, 2017|Categories: Gary's articles, Thinking Like A Pancreas Blog|0 Comments

Review of FiASP insulin and how it compares with other fast insulins

Novo Nordisk’s new FiASP insulin (short for Faster insulin Aspart) has hit the market in various parts of the world, and is awaiting FDA clearance here in the US.

By |2017-06-21T17:41:35+00:00June 21st, 2017|Categories: Thinking Like A Pancreas Blog|68 Comments
Load More Posts